Healthcare giant Baxter International (BAX) is recalling two lots of intravenous solution that may contain “particulate matter.”
The Illinois-based company issued the recall after a customer reported finding a bug in the IV solution. The customer noticed the insect before the solution was administered. Affected products include a 70% dextrose injection with an expiration date of July 31, 2016, and a 0.9% sodium chloride injection that expires on Nov. 30, 2016.
Administering contaminated IV solution, particularly without an in-line filtration system, can result in serious health problems, including allergic reactions and irritation/inflammation of tissues and organs. Injecting particular matter can also cause blocked blood vessels, which could lead to a stroke, heart attack, or organ damage.
Consumers should return the IV solution to Baxter International for credit. More information about affected lots can be found on the FDA website.
This article was updated to include Baxter’s statement and note that the bug was found by a customer. An earlier version of this story had incorrectly reported that it was found by a patient. The headline also was changed so that it no longer says a patient found the bug.